Journal
ACS APPLIED MATERIALS & INTERFACES
Volume 14, Issue 3, Pages 3662-3674Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsami.1c17861
Keywords
ceria; photocatalysis; Alzheimer's disease; antioxidant stress; phototherapy
Funding
- Natural Scientific Foundation of China (NNSFC) [22174123]
- Key University Science Research Project of Jiangsu Province [21KJA350003]
- Affiliated Hospital of Xuzhou Medical University [xyfyhx2021025]
- Public Experimental Research Center of Xuzhou Medical University
Ask authors/readers for more resources
This study explored the application of ceria nanoparticles in the treatment of Alzheimer's disease (AD). By introducing photothermal effect and photocatalytic activity, the treatment efficacy was improved. Biocompatibility and therapeutic effectiveness of Aβ-targeted inhibitory peptide-modified nanocomposites were verified in vitro and in vivo, suggesting the significant potential of nanotechnology in AD therapy.
Activities of catalase (CAT) and superoxide dismutase (SOD) of ceria nanoparticles (CeO2 NPs) provide the possibility for their application in nervous system oxidative stress diseases including Alzheimer's disease (AD). The addition of hot electrons produced by a plasma photothermal effect can expand the photocatalytic activity of CeO2 to the near-infrared region (NIR), significantly improving its redox performance. Therefore, we coated both ends of gold nanorods (Au NRs) with CeO2 NPs, and photocatalysis and photothermal therapy in the NIR are introduced into the treatment of AD. Meanwhile, the spatially separate structure enhances the catalytic performance and photothermal conversion efficiency. In addition, the photothermal effect significantly improves the permeability of the blood-brain barrier (BBB) and overcomes the shortcomings of traditional anti-AD drugs. To further improve the therapeutic efficiency, A beta-targeted inhibitory peptides were modified on the middle surface of gold nanorods to synthesize KLVFF@Au-CeO2 (K-CAC) nanocomposites. We have verified their biocompatibility and therapeutic effectiveness at multiple levels in vitro and in vivo, which have a profound impact on the research and clinical transformation of nanotechnology in AD therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available